Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News Successful Round of Multiple Academic Promotions for Institute 2022 Eight academics within the Institute of Immunology and Immunotherapy at the University of Birmingham have been promoted in the 2022 academic promotion round
04 August 2022 New Insights into Increases in Unexplained Paediatric Hepatitis Cases Professor Deirdre Kelly and Dr Zania Stamataki, Institute of Immunology and Immunotherapy, provide insights into increases of unexplained paediatric hepatitis.
03 August 2022 Successful Round of Multiple Academic Promotions for Institute 2022 Eight academics within the Institute of Immunology and Immunotherapy at the University of Birmingham have been promoted in the 2022 academic promotion round.
04 May 2022 Institute of Immunology and Immunotherapy welcomes new Professor of Regenerative Medicine Professor Ivan Wall has been appointed as Professor of Regenerative Medicine with the Institute of Immunology and Immunotherapy at the University of Birmingham.
03 May 2022 Insights shared from patient workshop on the use of artificial intelligence at capsule endoscopy Patients suffering with inflammatory bowel disease were invited to take part in a focused workshop at the University of Birmingham to assess their experiences.
07 March 2022 Opinion: Understanding the link between oral and gut health The relationship between oral health and overall health has been a focus for research for some time, explain Professors Iain Chapple and Tariq Iqbal.
16 February 2022 New study explores unique approach to treat a rare liver disease A UK research study looking into a new approach to treat primary sclerosing cholangitis, a rare disease where the body's immune attacks its own liver.
01 February 2022 Study shows impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.
31 January 2022 Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection Patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population, according to a new study led by the University of Birmingham.
22 December 2021 Booster vaccination strongly enhances COVID-19 immunity in care home residents and staff – study A COVID-19 booster vaccination markedly increases immune response in residents and staff within care homes, making it vital that people living and working in these settings get their third 'jab', a new study reveals.
20 December 2021 Birmingham Perspective: How might Omicron impact potential future COVID-19 variants? Adam Cunningham, Professor of Functional Immunity, speculates on how might the Omicron variant might affect future COVID-19 variants.
20 December 2021 University of Birmingham announces five new diabetes research studies The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
09 December 2021 Prior SARS-CoV-2 infection increases strength and quality of immune response in double vaccinated care home staff and residents, reveals study Elderly care home residents who have previously contracted and survived COVID-19 develop much stronger and higher antibody and cellular immune responses to two doses of vaccination, research finds.